Browse All

Current Filters

CLEAR FILTER x

TITLE

Nipocalimab Dose Selection for A Phase 3 Study in Adult Patients with Generalized Myasthenia Gravis

Author:Pérez-Ruixo, Juan-José   Zhu, Yaowei   Neyens, Martine   Jouvin, Marie-Helene   Ramchandren, Sindhu   Xu, Yan   Leu, Jocelyn   Dosne, Anne-Gaëlle   Xiong, Yuan   Valenzuela, Belén   Ling, Leona   Nandy, Partha   Sun, Hong   

Session Name:P1: Autoimmune Neurology: Myasthenia Gravis  

Topic:Autoimmune Neurology  

Program Number:P1.018  

Author Institution:Janssen Research & Development, Beerse, Belgium  Janssen Research & Development, Spring House, PA  Janssen Research & Development, Cambridge, MA  Janssen Research & Development, Knoxville, TN  Janssen Research & Development, Raritan, NJ  Janssen Research & Development, Princeton, NJ  

Cellular and In Vivo Preclinical Pharmacodynamics and Pharmacology of Nipocalimab, an Anti-FcRn Blocking Therapeutic Antibody

Author:Ling, Leona   Choudhury, Amit   Tyler, Steven   Avery, William   

Session Name:P10: Autoimmune Neurology: Inflammatory Neuropathy / Inflammatory Myopathy / Neuroimmunology / Clinical Care  

Topic:Autoimmune Neurology  

Program Number:P10.011  

Author Institution:Janssen Pharmaceuticals (J&J), Cambridge, MA  Janssen Immunology, Titusville, NJ  Orna Therapeutics, Cambridge, MA  Kisbee Therapeutics, Cambridge, MA